Free Trial

TuHURA Biosciences (HURA) Competitors

$5.18 +0.20 (+4.02%)
(As of 01:19 PM ET)

HURA vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ALVO, AMPE, ARAV, ACABW, and ACABU

Should you be buying TuHURA Biosciences stock or one of its competitors? The main competitors of TuHURA Biosciences include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Alvotech (ALVO), Ampio Pharmaceuticals (AMPE), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Atlantic Coastal Acquisition Corp. II (ACABU). These companies are all part of the "pharmaceutical products" industry.

TuHURA Biosciences vs.

TuHURA Biosciences (NASDAQ:HURA) and 180 Life Sciences (NASDAQ:ATNFW) are both manufacturing companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, dividends, valuation, risk, community ranking, profitability, earnings and analyst recommendations.

In the previous week, TuHURA Biosciences had 1 more articles in the media than 180 Life Sciences. MarketBeat recorded 1 mentions for TuHURA Biosciences and 0 mentions for 180 Life Sciences. TuHURA Biosciences' average media sentiment score of 1.00 beat 180 Life Sciences' score of 0.00 indicating that TuHURA Biosciences is being referred to more favorably in the media.

Company Overall Sentiment
TuHURA Biosciences Positive
180 Life Sciences Neutral

Company Net Margins Return on Equity Return on Assets
TuHURA BiosciencesN/A N/A N/A
180 Life Sciences N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TuHURA BiosciencesN/AN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

TuHURA Biosciences and 180 Life Sciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
TuHURA BiosciencesN/AN/A
180 Life SciencesN/AN/A

TuHURA Biosciences currently has a consensus target price of $15.00, suggesting a potential upside of 189.58%. Given TuHURA Biosciences' stronger consensus rating and higher probable upside, equities research analysts plainly believe TuHURA Biosciences is more favorable than 180 Life Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TuHURA Biosciences
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
180 Life Sciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

TuHURA Biosciences beats 180 Life Sciences on 5 of the 5 factors compared between the two stocks.

Get TuHURA Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for HURA and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HURA vs. The Competition

MetricTuHURA BiosciencesPharmaceutical Preparations IndustryManufacturing SectorNASDAQ Exchange
Market CapN/A$6.85B$2.20B$8.79B
Dividend YieldN/A7.95%2.67%4.03%
P/E RatioN/A8.6926.1316.06
Price / SalesN/A411.21496.00103.52
Price / CashN/A22.5640.2231.73
Price / BookN/A5.512.254.69
Net IncomeN/A$153.74M$165.18M$223.56M
7 Day PerformanceN/A0.16%0.59%1.69%
1 Month PerformanceN/A16.26%0.12%5.76%
1 Year PerformanceN/A42.04%13.31%31.80%

TuHURA Biosciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HURA
TuHURA Biosciences
N/A$5.18
+4.0%
$15.00
+189.6%
N/A$0.00N/A0.00N/AUpcoming Earnings
Analyst Forecast
Positive News
ATNFW
180 Life Sciences
N/A$0.01
flat
N/A-9.0%$0.00N/A0.007Positive News
Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/AGap Down
AEHAW
Aesther Healthcare Acquisition
N/A$0.05
flat
N/A-8.0%$0.00N/A0.002Gap Up
AIMDW
Ainos
N/A$0.03
flat
N/AN/A$0.00$65,122.000.0040Positive News
ALVOW
Alvotech
N/A$3.01
-5.9%
N/A+130.7%$0.00$306.77M0.004Positive News
ALVO
Alvotech
3.1896 of 5 stars
$12.92
-0.8%
N/A+45.3%$0.00$93.38M-4.881,026Upcoming Earnings
AMPE
Ampio Pharmaceuticals
N/A$0.00
flat
N/A-99.9%$0.00N/A0.0020
ARAV
Aravive
1.7906 of 5 stars
$0.04
flat
N/AN/A$0.00$9.14M-0.0420News Coverage
High Trading Volume
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.03
flat
N/A-45.5%$0.00N/A0.004Positive News
ACABU
Atlantic Coastal Acquisition Corp. II
N/A$12.54
flat
N/A+19.1%$0.00N/A0.004Positive News

Related Companies and Tools


This page (NASDAQ:HURA) was last updated on 11/6/2024 by MarketBeat.com Staff
From Our Partners